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Abstract 
A recent experimental study found that the binding affinity between the cellular receptor 
human angiotensin converting enzyme 2 (ACE2) and receptor-binding domain (RBD) in 
spike (S) protein of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
is more than 10-fold higher than that of the original severe acute respiratory 
syndrome coronavirus (SARS-CoV). However, main-chain structures of the SARS-CoV-2 
RBD are almost the same with that of the SARS-CoV RBD. Understanding physical 
mechanism responsible for the outstanding affinity between the SARS-CoV-2 S and ACE2 
is the "urgent challenge" for developing blockers, vaccines and therapeutic antibodies against 
the coronavirus disease 2019 (COVID-19) pandemic. Considering the mechanisms of 
hydrophobic interaction, hydration shell, surface tension, and the shielding effect of water 
molecules, this study reveals a hydrophobic-interaction-based mechanism by means of which 
SARS-CoV-2 S and ACE2 bind together in an aqueous environment. The hydrophobic 
interaction between the SARS-CoV-2 S and ACE2 protein is found to be significantly 
greater than that between SARS-CoV S and ACE2. At the docking site, the hydrophobic 
portions of the hydrophilic side chains of SARS-CoV-2 S are found to be involved in the 
hydrophobic interaction between SARS-CoV-2 S and ACE2. We propose a method to 
 
                           
design live attenuated viruses by mutating several key amino acid residues of the spike 
protein to decrease the hydrophobic surface areas at the docking site. Mutation of a small 
amount of residues can greatly reduce the hydrophobic binding of the coronavirus to the 
receptor, which may be significant reduce infectivity and transmissibility of the virus. 
Introduction 
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged 
as a human pathogen, causing fever, severe respiratory diseases, pneumonia, and systemic 
inflammatory response syndrome, leading to a worldwide sustained pandemic. Both 
SARS-CoV-2 and the original severe acute respiratory syndrome coronavirus (SARS-
CoV) enter human cells by protein-protein docking to human angiotensin converting 
enzyme 2 (ACE2) on the host cell membrane via CoV spike (S) glycoproteins. A recent 
experimental study found that the binding affinity between ACE2 and the receptor-
binding domain (RBD) of the S protein of SARS-CoV-2 is more than 10-fold higher than 
that of SARS-CoV, which may contribute to the higher infectivity and transmissibility of 
SARS-CoV-2 compared to SARS-CoV (1-3).  
Molecular structures of the S protein of SARS-CoV-2 have been observed at high 
resolution by using cryo-electron microscopy (cryo-EM) (4-6). The complex structures of 
ACE2 bound to the SARS-CoV-2 S have also been experimentally determined (7-10). 
Surprisingly, all these experiments showed that the backbone structures of the RBD of 
SARS-CoV-2 S are almost same as that of SARS-CoV S (see Fig. 1a) (7, 11). A molecular 
dynamic (MD) study has showed that the binding energy of SARS-CoV-2 S to ACE2 is 
almost same as that of SARS-CoV S to ACE2 (12). Another MD simulation study showed 
that the interaction ability between SARS-CoV-2 RBD and ACE2 decreased by 35.6% 
compared with the interaction ability of SARS-CoV RBD and ACE2, attributed to the 
lack of several hydrogen bonds between SARS-CoV-2 RBD and ACE2, the molecular 
binding free energy is therefore significantly reduced (13). Therefore, 
physical mechanisms responsible for the strong binding affinity between SARS-CoV-2 
RBD and ACE2 haven’t be disclosed by the binding energy calculations. The reason why 
the affinity of SARS-CoV-2 RBD and ACE2 far exceeds that of SARS-CoV RBD and 
 ACE2 may be caused by a long-range adhesion mechanism between the ligand and 
receptor. 
Specific binding of SARS-CoV-2 S and ACE2 forms the joint structure between the 
coronavirus and the host cell that enable the coronavirus enter the host cell (14). The chief 
characteristic of proteins that allows their diverse set of functions is their ability to dock 
with other proteins specifically and tightly. Protein-protein docking is therefore 
considered one of the miracles of nature, in that almost all biological existence, 
functionalization, diversity, and evolution rely on it as the most important mechanism, 
principle, and motivation. At present the underlying physical mechanisms responsible 
for the specific docking of SARS-CoV-2 RBD and ACE2 are not fully understood (15), 
which hinders the development of anti-coronavirus drugs and therapies. Surprisingly, in 
natural intracellular environment and extracellular medium, protein-protein docking are 
usually the contacts of high specificity established between two or more specific 
protein molecules, and erroneous protein-protein docking rarely occurs (16). The classic 
problem of protein-protein docking is the question of how a protein find its partner in its 
natural environment (17). 
Protein-protein docking is mainly guided by a variety of physical forces as follows: (i) 
hydrophobic effect, (ii) electrostatic forces, (iii) van der Waals forces, (iv) hydrogen 
bonding, (v) ionic bonding, (vi) entropy. Among them, the hydrogen bonding and 
hydrophobic effect are normally thought to play a decisive role (15, 18). In extracellular 
medium, hydrogen-bond competing is always present with water. Because bulk water 
interferes with reversible biological processes and enthalpy-entropy compensation occurs 
during hydrogen-bond formation, the mechanisms and the extent to which hydrogen 
bonds contribute to protein-protein docking are not well understood. In particular, whether 
hydrogen bonds formation regulate protein-protein docking remains a long-standing 
problem with poorly defined mechanisms (15, 19-23). It is worth noting that hydrogen 
bonds formation is not a long-range physical force. Considering that only several 
hydrogen bonds between SARS-CoV-2 RBD and ACE2 can be identified in the complex 
(7-10, 13), the docking between the coronavirus and the host cell may be not dominated 
by hydrogen bond pairing between them. 
                           
Water molecules have a very strong polarity (24). The interaction of protein surface with 
the surrounding water is often referred to as protein hydration layer (also sometimes called 
hydration shell) and is fundamental to structural stability of protein, because non-aqueous 
solvents in general denature proteins (25). The hydration layer around a protein has been 
found to have dynamics distinct from the bulk water to a distance of 1 nm and water 
molecules slow down greatly when they encounter a protein(26). Thus, hydrophilic side 
chains of proteins are normally hydrogen bonded with surrounding water molecules in 
aqueous environments, thereby preventing the surface hydrophilic side-chains of proteins 
from randomly hydrogen bonding together (26, 27) (24). This is the reason why proteins 
usually do not aggregate and crystallize in unsaturated aqueous solutions(28).  
The region of the protein responsible for binding another molecule is known as 
the docking site (also sometimes called binding site) and is often a depression on the 
molecular surface. Before the docking, external hydrophilic side-chains of SARS-CoV-2 
S and ACE2 must hydrogen bonded with water molecules in extracellular medium, so it 
is difficult to explain how the hydrophilic side-chains at the docking site can get rid of 
their hydrogen-bonded water molecules, and then interact with each other during the 
docking process (7-10).  
The key to SARS-CoV-2 infection is that the S protein can specifically bind to the ACE2 
in a strong affinity manner. This binding ability is mediated by the tertiary structure of the 
protein, which defines the docking site, and by the chemical properties of the surrounding 
amino acids' side chains (29). The hydrophobicity of the protein surface is the main factor 
that stabilizes the protein-protein binding, thus hydrophobic interaction among proteins 
may play an important role in determining the protein-protein binding affinity (18, 30, 31)。 
Results 
Although there are many hydrophilic side chains on the surface of SARS-CoV-2 RBD, 
the surface of SARS-CoV-2 RBD is not completely hydrophilic. Hydrophobic side-chains 
of many species of residues, such as glycine (Gly), alanine (Ala), valine (Val), leucine 
(Leu), isoleucine (Ile), proline (Pro), phenylalanine (Phe), methionine (Met), and 
tryptophan (Trp) are found on the surface of the RBD, as shown in Fig. 1b (4-10). It is 
 worth noting that hydrophilic side-chains are not completely hydrophilic. The 
hydrophilicity of hydrophilic side-chains is normally expressed by C=O or N-H2 groups 
at their ends, and the other portions of hydrophilic side-chains are hydrophobic, because 
the molecular structures of these portions are basically alkyl and benzene ring structures, 
as shown in Fig. 2. It means that there are a large number of water molecules surround the 
hydrophobic surface areas of the RBD rather than hydrogen bonded with the RBD. The 
characteristic of these water molecules surrounding the hydrophobic surface areas is that 
their hydrogen bonding network is more ordered than free liquid water molecules, that is, 
their entropy is lower. 
We simulated the hydration layer of SARS-CoV-2 RBD by using the molecular dynamic 
method. The simulation results show that only about 30.6% of the water molecules in the 
innermost hydration layer surrounding the RBD hydrogen bonded with the RBD (see Fig. 
3), due to exposure of many hydrophobic surface areas on the RBD (4-10, 18, 30). Many 
hydrophobic areas on the surface of the RBD are found to be connected with each other, 
which indicates that surface tension affect the surface properties of docking site of the 
RBD (see Fig. 1b) (32). Hydration layer of an ACE2 is also obtained by using MD 
simulation, showing that only about 21.3% of the water molecules in the innermost 
hydration layer surrounding the ACE2 hydrogen bonded with the ACE2 (see Fig. 4). The 
existence of hydrophobic surface in large areas of both SARS-CoV-2 RBD and ACE2 
indicates that a strong hydrophobic interaction may occur between them. 
To illustrate hydrophobic binding effect in the complex of SARS-CoV-2 RBD and ACE2, 
we mark the hydrophobic surface areas of the two proteins at the docking site based on 
the experimentally determined structure as shown in Fig. 5 (9). By analyzing the details 
of the interface between the RBD and ACE2 of the complex, it can be easily found that 
the docking causes the hydrophobic surface areas of the two protein contact and collapse 
together at the docking site. The hydrophobic interaction surface areas of the RBD to 
ACE2 accounts for 76% of the total contact area of the RBD (see Fig. 5). The degree of 
hydrophobic paring is very high and the hydrophobic interaction most likely play an 
important role in the protein-protein docking (18, 30). The hydrophobic portions of 
hydrophilic side-chain obviously participate in the hydrophobic interaction between the 
                           
RBD and ACE2 at the docking site (see Fig. 5). It is most likely that the hydrophobic 
interaction at the docking site enable the hydrophilic side-chains to get rid of their original 
hydrogen-bonded water molecules, so that the hydrophilic side-chains can participate in 
the hydrophobic interaction via their hydrophobic portions, namely enthalpy-entropy 
compensation occurs during the docking (15) (19-23). 
Comparing the experimentally determined molecular structure of the complex of SARS-
CoV RBD and ACE2, the corresponding hydrophobic surface areas of the two proteins at 
the docking site that involved in the hydrophobic binding interaction are marked in Fig. 
6. By analyzing the docking site, it can be found that the hydrophobic surface areas 
involved in hydrophobic effect of the docking of SARS-CoV RBD and ACE2 is 
significantly smaller than that of the docking of SARS-CoV-2 RBD and ACE2 (see Fig. 
6). Because many hydrophobic surface areas on ACE2 face to face with hydrophilic 
groups of SARS-CoV-2 RBD at the docking site. This means that the hydrophobic 
interaction between the SARS-CoV RBD and ACE2 is significantly less than that of 
between SARS-CoV-2 RBD and ACE2, due to the relatively poor hydrophobic pairing 
between SARS-CoV RBD and ACE2. This explains why the SARS-CoV-2 S exhibits a 
much higher affinity to the ACE2 protein than the SARS-CoV. We calculate the size of 
hydrophobic surface areas of SARS-CoV-2 RBD and SARS-CoV RBD at binding site 
that participate in the hydrophobic binding interaction with ACE2. The hydrophobic 
surface area of SARS-CoV-2 RBD (about 867.4Å2) that involved in the hydrophobic 
interaction docking with ACE2 is about 2.03 times of that (about 427.3Å2) of the SARS-
CoV RBD (see Fig. 5,6).  
We simulate the hydration layers of the complex of ACE2 bound to SARS-CoV-2 RBD 
and the complex of ACE2 bound to SARS-CoV RBD by using MD method, respectively. 
Two cross-sectional views of the two hydration shells at the docking sites are shown in 
FIG. 7. From the cross-sectional view of the complex of ACE2 and SARS-CoV-2 RBD, 
we can see that the docking causes the hydration shells of the RBD and ACE2 to be 
integrated. This means that the docking cause many ordered water molecules in the 
original hydration shells of the RBD and ACE2 at the docking site transformed into free 
water molecules, driven by an increase in entropy. At the docking site of the RBD and 
 ACE2, the side-chains of those hydrophilic residues have lost their original hydrogen-
bonded water molecules and formed new hydrogen bonding, electrostatic interaction and 
hydrophilic interaction with each other, which results in the contact area of hydrophobic 
interaction at the docking site increasing. By comparing the hydrophobic surface areas of 
ACE2 at the docking site before and after docking with SARS-CoV-2 RBD, we found 
that the docking causes some disconnected hydrophobic surface areas at the docking site 
to be connected. Above all, it can be considered that the docking of SARS-CoV-2 RBD 
and ACE2 is mainly regulated by the hydrophobic effect at the binding site, that is, by the 
entropy increases. The hydrophobic interaction and enthalpy-entropy compensation at the 
binding site most likely cause the hydrophilic side-chains in this region to get rid of their 
original hydrogen-bonded water molecules, and promote formation of new hydrogen 
bonding and electrostatic attraction relationship among these hydrophilic residue-side 
chains at the binding site. 
Mutation of some amino acid residues can reduce the hydrophobic surface areas of the 
SARS-CoV-2 RBD at the docking site and may significantly decrease the hydrophobic 
interaction between of SARS-CoV-2 S and ACE2, thereby greatly reducing the affinity 
between them. By analyzing the hydrophobic side-chains at the binding site of the 
complex of the SARS-CoV-2 RBD and ACE2, we tried to mutate the 6 amino acid 
residues to aspartame Acid in the RBD, see Fig. 8. For only 6 amino acid residues are 
mutated, the tertiary structure of the main chain of the mutated RBD may be the same as 
that of the original RBD. We simulated the molecular structure of the complex of the 
mutated RBD and ACE2 by using molecular dynamics NVT ensemble and NVERE 
relaxation algorithm (25). The simulation results show that the hydrophobic interaction 
areas of the mutant RBD in docking with ACE2 is greatly reduced by about 50%, which 
is similar to the size of hydrophobic interacting area of the SARS-CoV RBD bound to 
ACE2. Through such a mutation method, only a few amino acid residues mutation most 
likely can greatly reduce the affinity of the virus and the receptor, which may significantly 
reduce its infectiousness. This method may be used to design an attenuated virus that is 
very similar to origin coronavirus, but most likely retains its immunogenicity and triggers 
the immune response. By mutating several amino acid residues of SARS-CoV-2 RBD, 
                           
the hydrophobic interaction of SARS-CoV-2 RBD and ACE2 can be significantly 
disrupted, thereby significantly reducing the binding efficiency of the virus to the host 
cell, which may help to slow down SARS-CoV-2 transmission from person to person. 
Recently, molecular structures of a complex of human monoclonal antibody CB6 and 
SARS-CoV-2 RBD have been experimentally determined (26). By analyzing the 
distribution of the hydrophobic surface areas at the binding site of the complex, we found 
that the contact hydrophobic surface area of the RBD and CB6 is not big enough to exhibit 
the blocking effect and neutralizing capacity of the antibody to the virus. However, it is 
worth noting that the docking site of antibody CB6 is connected to a large hydrophobic 
area, as shown in Fig. 9A. This large hydrophobic region most likely contribute to 
hydrophobic interaction between the RBD and CB6 as an entropy-
driven spontaneous process, thereby strengthening the binding of the CB6 and RBD. 
Molecular structures of another complex of human monoclonal antibody B38 and RBD 
of SARS-CoV-2 have also been experimentally determined (31). At the docking site, 
antibody B38 is also connected to a large hydrophobic area, as shown in Fig. 9B. 
Therefore, in evaluating hydrophobic interactions among proteins, hydrophobic surface 
areas connected with the docking site should be taken into consideration for the 
hydrophobic effect.  
Conclusion 
The high affinity between SARS-CoV-2 S and ACE2 most likely resourced from 
hydrophobic effect among the hydrophobic surface areas of the two protein at the binding 
site. The hydrophobic interaction and enthalpy-entropy compensation in the binding 
region between the S protein and ACE2 protein most likely cause the hydrophilic residues 
in this region to get rid of the hydrogen-bonded water molecules, and to promote hydrogen 
bonding and electrostatic attraction among these hydrophilic side-chains at the binding 
site. The hydrophobic portions of the hydrophilic side chains at the docking site participate 
in the hydrophobic interaction between SARS-CoV-2 S and ACE2. The affinity between 
SARS-CoV-2 RBD and ACE2 can be characterized by calculation the hydrophobic 
contact area between them at the docking site. This method shows that the hydrophobic 
interaction between the SARS-CoV-2 S and ACE2 protein is significantly greater than 
 that between SARS-CoV S and ACE2. The degree of hydrophobic paring between SARS-
CoV-2 RBD and ACE2 is very high. This explains why the affinity of SARS-CoV-2 RBD 
and ACE2 far exceeds that of SARS-CoV RBD and ACE2. Only several amino acid 
residues mutation may greatly reduce the affinity of SARS-CoV-2 and ACE2 receptor, 
which may significantly reduce its infectiousness. This method may be used to design an 
attenuated virus that is very similar to origin coronavirus, but still retains its 
immunogenicity and triggers the immune response. In evaluating hydrophobic interaction 
between virus and the receptor, hydrophobic surface areas connected with the binding 
sites should be taken into consideration that most likely play a role of increasing the 
hydrophobic effect in their docking.  
Materials and Methods  
Protein structures 
In this study, many experimentally determined native structures of proteins are used to 
study the mechanism triggering docking of SARS-CoV-2 S and ACE2. All the three-
dimensional (3D) structure data of protein molecules are resourced from the PDB database, 
including the experimentally determined the RBD of SARS-CoV-2 S, RBD of SARS-
CoV S, ACE2, antibody CB6 and their complexes, et al. IDs of these proteins according 
to PDB database are marked in the Fig.1, Fig.3, Fig.4, Fig.5, Fig.6, Fig.7, Fig.8, and Fig.9. 
In order to show the distribution of hydrophobic areas on the surface of the SARS-CoV-
2 RBD, of SARS-CoV RBD, ACE2, antibody and their complexes at the binding sites in 
these figures, we used the structural biology visualization software PyMOL to display the 
protein hydrophobic surface areas. 
MD simulations 
The simulation of the hydration shells for the RBD of SARS-CoV-2 S and ACE2 was 
executed using NAMD simulator (33) with the CHARMM36 potential (34, 35) in an NVT 
ensemble at 300K for 5000000 time steps (2 fs per time step). Water molecules were built 
in these models 10Å away from the two protein structures. In the simulations, the 
hydration shells were gradually formed surrounding these structures. The shapes of 
hydration shells were achieved by showing water molecules within 3Å distance of the 
                           
proteins’ surfaces. The main chain structures of these model have no change during the 
hydration shells simulations. The van der Waals (VDW) interaction was truncated at 10 
Å. We tried to mutate 6 amino acid residues of the RBD region of the complex of the 
spiked S protein of the COVID-19 virus and the RBD region of the docking complex of 
ACE2 protein. By using the molecular dynamics NVT ensemble (300K) and the NVERE 
relaxation algorithm (36), we simulated the molecular structure of the complex of docked 
spike protein and ACE2 protein. The simulation results shows that the main chain 
structure of the complex do not change due to mutation. The NVERE relaxation features 
the optimization of potential energy through long MD trajectories and large deformation, 
and it is capable of finding more stable equilibrium configurations than common 
optimization algorithms (36). 
Calculation of hydrophobic surface area of proteins involved in docking  
Affinity of RBD and ACE2 can be characterized by calculating the size of the 
hydrophobic contact area in the complex structures. The hydrophobic interaction 
regulating the docking of S protein and ACE2 mainly occurs at the docking sit. We used 
molecular 3D structure display software PyMOL to draw the hydrophobic surface areas 
which at least contacting another hydrophobic surface area at the docking site. Since these 
hydrophobic surface areas are very close to each other, we think these hydrophobic 
surfaces participate in the hydrophobic effect. We calculated the hydrophobic surface 
areas involved in the hydrophobic interaction between RBD and ACE2 in this study.  
  
Fig.1 a Comparison of the complex of SARS-CoV-2 RBD bound to ACE2 and the 
complex of SARS-CoV RBD bound to ACE2(7) (11). b Molecular surface of SARS-
CoV-2 RBD (hydrophobic surface areas is highlighted by green and yellow) (7) 
                           
 
Fig.2 Hydrophobic portions of hydrophilic amino acid side-chains (hydrophobic portions 
are highlighted by green)
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Fig.3 a Molecular structure of SARS-CoV-2 RBD (9) (PDBID: 6LZG) .b Molecular 
surface of SARS-CoV-2 RBD with supplementation of hydrogen atoms .c Hydrogen-
bonded water molecules to the RBD. d The RBD and hydrogen-bonded water molecules. 
e Distribution of hydrogen-bonded water molecules at docking site of the RBD, the 
exposed hydrophobic surface is marked with dash lines. 
                           
 
Fig.4 a Molecular structure of ACE2 (9) (PDBID: 6LZG). b Molecular surface of ACE2 
protein with supplementation of hydrogen atoms. c Water molecules hydrogen-bonded to 
ACE2. d ACE2 and hydrogen-bonded water molecules. 
  
Fig.5 a Distribution of hydrophobic surface areas on the ACE2 involved in hydrophobic 
effect at the docking site (green surface areas) (PDBID: 6LZG). b Distribution of 
hydrophobic surface areas on the SARS-CoV-2 RBD involved in hydrophobic effect at 
the docking site (green surface areas), c The hydrophobic surface areas contacting in the 
complex of ACE2 and the RDB (green surface areas) (9) 
                           
 
Fig.6 a Distribution of hydrophobic surface areas on the ACE2 involved in hydrophobic 
effect at the docking site (green surface areas) (PDBID: 2AJF), b Distribution of 
hydrophobic surface areas on the SARS-CoV RBD involved in hydrophobic effect at the 
docking site (green surface areas), c The hydrophobic surface areas contacting in the 
direction of docking in the complex of ACE2 and the RDB (green surface areas) (11) 
  
Fig.7 a Hydrated shell of SARS-CoV-2 RBD and ACE2, the grid represents the hydrated 
shell (PDBID: 6LZG) (9). b ,c cross-sectional views of the hydration shells at the docking 
site of SARS-CoV-2 RBD and ACE2 (PDBID: 6LZG), e ,d cross-sectional views of the 
hydration shells at the docking site of SARS-CoV RBD and ACE2 (PDBID: 2AJF) (11) . 
                           
 
Fig.8 a Six hydrophobic residues in SARS-CoV-2 RBD at the docking site (PDBID: 
6LZG) (9).b The distribution of hydrophobic surface areas of the RBD after mutating the 
6 hydrophobic residues to aspartic Acid at the docking site. 
  
Fig.9 a The hydrophobic surface areas of the human monoclonal antibody CB6 and 
SARS-CoV-2 RBD at the binding site (green surface areas) (PDBID: 7C01 ) (37). b The 
hydrophobic surface areas of the human monoclonal antibody B38 and SARS-CoV-2 
RBD at the binding site (green surface areas) (PDBID: 7C01 ) (31). 
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